Physician

Alexander James Lietz, MD

According to 2025 Medicare claims, Alexander Lietz, MD (NPI: 1790244713) practices infectious disease, with the plurality of this provider's patient population coming from Williamson, IL. This provider's primary affiliated billing organization is SOUTHERN ILLINOIS MEDICAL SERVICES, NFP (NPI: 1770656837; TIN: 205521741) and primary practice location at 62901-1462. Lietz is affiliated with the IRCCO (ACO ID: A2619) and Quality Health Partners, LLC (ACO ID: A5553), participating under the MSSP model.

Lietz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 109 traditional Medicare patients, billed 266 HCPCS/CPT codes, and received $25,110 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 80 prescription claims across 23 beneficiaries totaling $128,463 in drug costs, led by Juluca (Dolutegravir/Rilpivirine). Open Payments data shows 11 records totaling $254. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $2,328 to $128,463. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$13K$25K2024 Medicare payment: $25,110 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024109266$25,110

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$64K$128K2019 Drug cost: $2,328 (USD; Tot_Drug_Cst)2020 Drug cost: $33,064 (USD; Tot_Drug_Cst)2021 Drug cost: $63,739 (USD; Tot_Drug_Cst)2022 Drug cost: $35,336 (USD; Tot_Drug_Cst)2023 Drug cost: $52,846 (USD; Tot_Drug_Cst)2024 Drug cost: $128,463 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191949$2,328
202045235$33,064
202143383$63,739
202226192$35,336
2023N/R51$52,846
20242380$128,463

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes6871$134
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more1212$120
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes59120$91
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's2026$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JulucaDolutegravir/Rilpivirine13390$46,928
BiktarvyBictegrav/Emtricit/Tenofov Ala11330$45,883

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$254Gilead Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexander James Lietz, MD?

Tedicare shows public-source Medicare data for Alexander James Lietz, MD (NPI 1790244713), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander James Lietz, MD have ACO affiliation data?

Alexander James Lietz, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and Quality Health Partners, LLC (MSSP, ACO ID A5553).

What billing organization is linked to Alexander James Lietz, MD?

Alexander James Lietz, MD is linked to SOUTHERN ILLINOIS MEDICAL SERVICES, NFP (billing NPI 1770656837) in the available physician profile data.

Does Alexander James Lietz, MD have Open Payments data?

Alexander James Lietz, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.